Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients - Wikidata - awgldk - TriplyDB

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

http://www.wikidata.org/entity/Q37394399

about

Trash or Treasure: extracellular microRNAs and cell-to-cell communication Extracellular RNA in aging Extracellular MicroRNA in liquid biopsy: applicability in cancer diagnosis and prevention Circulating biomarkers to monitor cancer progression and treatment New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies Decoding the Secret of Cancer by Means of Extracellular Vesicles MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer Roles for miRNAs in endocrine resistance in breast cancer Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids HypoxamiRs and cancer: from biology to targeted therapy Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patients Neoadjuvant therapy of early stage human epidermal growth factor receptor 2 positive breast cancer: latest evidence and clinical implications Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer Decoding the usefulness of non-coding RNAs as breast cancer markers ApoptomiRs of Breast Cancer: Basics to Clinics Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.Usefulness of miRNA profiles for predicting pathological responses to neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer.Emerging therapies for breast cancer Down-Regulation of MicroRNA-210 Confers Sensitivity towards 1'S-1'-Acetoxychavicol Acetate (ACA) in Cervical Cancer Cells by Targeting SMAD4 Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy.Circulating microRNAs as biomarkers for inflammatory diseases.Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel.An Argonaute 2 switch regulates circulating miR-210 to coordinate hypoxic adaptation across cells.Circulating miR-148b and miR-133a as biomarkers for breast cancer detection.Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer.Circulating miRNAs as new blood-based biomarkers for solid cancers.Deep Sequencing of Serum Small RNAs Identifies Patterns of 5' tRNA Half and YRNA Fragment Expression Associated with Breast Cancer.Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia.Regulation of cancer metastasis by cell-free miRNAs.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.Critical analysis of the potential for microRNA biomarkers in breast cancer management.Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer.miR-30e* is an independent subtype-specific prognostic marker in breast cancer

P2860

Q21131238-0F7B6313-C3B3-4362-88E8-A6022F942098 Q26741143-05601AD7-632F-4B92-B523-0DE7D51D626E Q26742027-742D946F-0A2B-4C21-AA22-CDA47B568E1E Q26745985-AFE05D9A-A19A-4159-B629-4E4F5E907CEA Q26748881-51DDD492-E36D-4545-86EE-234B7FCCB16A Q26767179-97C24263-B26E-4A45-BAE8-EBB0861C5695 Q26775086-7F4E358B-6DFB-46F4-91B2-BEB5C4DACB77 Q26783076-2852F26D-A1CF-4EF8-B7B5-1DF0C2E062FE Q26796590-3C7A43FE-FF4F-429A-8197-FE5AE642F4C5 Q26801108-08C1B15C-EFF7-492C-AAB4-E30957DF39B7 Q26825022-BD64020A-CD87-437E-A54D-23BF237B230C Q26863298-DCC2F8AE-2F1A-47AD-A64C-EC32EAAB26BB Q26996424-CDB6FE37-497A-46B0-A68A-0A02C8F5220E Q27001729-71A2D79E-BA7A-4EC7-83A8-4D11373275DE Q28066481-F1A43C5A-0949-4CA9-A592-BECD7F173A81 Q28069370-F80C25C4-1E16-45BD-BFD0-22AA99804C65 Q28072414-DA0B816E-B257-4A74-BC2D-79D798BBB972 Q33579853-179311BC-1D29-4B74-A286-70A18631CC8E Q33585105-D9EDB852-3993-4D27-96DA-0321B4B4AE71 Q33591140-59277E90-17BA-464D-B3B3-1718F2E3736C Q33599465-8A2CA692-F7A7-40A7-BB94-BB78BF8D6757 Q33617949-602A3B32-3BE9-4E79-8260-B1CF30EDA115 Q33654659-008E0812-C0E1-46AC-9460-21C98638FFD2 Q33838622-8D2FB738-3951-4483-8F80-2499185F9756 Q33844289-E2EE9DED-A699-4CB4-BC64-55AB94D00EB2 Q33882249-B13DFF3A-7AD9-455D-AED2-70D4345F7D9D Q34066078-B8DBA9F1-499D-4773-BF4A-D0E4D8C69B0E Q34150859-F8A83095-9F07-44AA-9021-F83F1D1938BD Q34221705-8293E029-ADA7-4C8B-8509-5CCF6DCF0964 Q34241079-ABE1DD04-5DB5-4873-96D0-53D02343BDC8 Q34331651-E7E3F2A6-31E4-44FD-9DB5-546CDD661A66 Q34662408-1C0C09A7-953F-4F6C-B856-62B555ECF146 Q34919573-313977A3-460F-49AB-9746-7E242DCCCA7D Q35034340-F9F70941-641F-43C9-8B91-FABD38DE65A1 Q35094742-2275D12F-C39D-4D6B-8267-9FDBB35236E4 Q35137273-5F2C05D7-C566-4EB8-9906-DE77807EF45E Q35203556-5E9AFBBE-5A99-4978-AC6C-A1973158770B Q35402769-7A6CEEFC-2DE2-4CFA-A062-B88BCEC4DE1C Q35740045-2E34F70D-3C1B-4085-8024-709F83AFEAE2 Q35863168-BB4FE2F3-8B3F-48C8-AB8C-EF02A0206191

P2860

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

http://www.wikidata.org/entity/Q37394399

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 October 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Plasma microRNA 210 levels cor ...... ence in breast cancer patients

@en

Plasma microRNA 210 levels cor ...... nce in breast cancer patients.

@nl

type

label

Plasma microRNA 210 levels cor ...... ence in breast cancer patients

@en

Plasma microRNA 210 levels cor ...... nce in breast cancer patients.

@nl

prefLabel

Plasma microRNA 210 levels cor ...... ence in breast cancer patients

@en

Plasma microRNA 210 levels cor ...... nce in breast cancer patients.

@nl

P1433

Q37394399-1064A16C-BB95-4B39-BF29-C489C3882FF1

P1476

Q37394399-94786226-EDE4-456D-9C8A-4A471E7EAF77

P2093

Q37394399-1E34C187-A3CD-4D4F-9629-6156805BDA94

Q37394399-6BC0F04F-1FC4-43B1-82AB-C5DABDF87F8C

Q37394399-A7696F13-B60F-40F6-A820-0398FF159A09

Q37394399-E8708554-F71A-4655-A6D1-9DC829A83DEF

Q37394399-ECAA7993-3373-4977-AC5E-0BF4325B6684

Q37394399-F7954621-754A-47EE-BCF1-6DE35709C548

P2860

Q37394399-04D3EFC9-E145-404F-8B11-71D40AA6D291

Q37394399-09CC9391-4A93-416A-8685-2321255486BF

Q37394399-0ADFC7AE-C778-4F8C-B119-8DCF8FC2B6BB

Q37394399-19E28905-54A5-496F-9293-EA5DA54F5C19

Q37394399-1CC6036E-11BF-4C3E-A5F2-AE3AE8F00575

Q37394399-242AC87E-AED8-4CA0-A2EC-316FFBC96716

Q37394399-2B6C408B-499C-4A5A-A73D-A09C924F5285

Q37394399-2BDCE550-728D-4CD7-B788-FCEAE7387EC1

Q37394399-36EA3934-1828-4884-8E7D-AC44DCE42145

Q37394399-3B43F2CF-9704-4A26-842A-D20BC55AEEC3

P304

Q37394399-00161E93-429D-4FFC-9C9E-38C5C6F6D682

P31

Q37394399-DA23A4D3-1A4E-4B96-95C9-3C8820E28D31

P356

Q37394399-DEBA4A76-984B-4E2E-B8DF-A051E06458BB

P407

Q37394399-46EB3749-78F0-4513-ABF0-4FEB8936F6B4

P433

Q37394399-5244054A-09AE-4926-9929-811E9D3B2761

P478

Q37394399-055578C1-8B99-49CF-9B3F-AC2ADED0CD19

P50

Q37394399-1FE4DCF5-A62A-4668-8907-841395197807

Q37394399-664CCC84-11C1-497D-B465-04429DC6F371

Q37394399-711DABA9-43E8-44AC-B9A2-E0CA1E410070

Q37394399-8BA92EE9-AE83-4AA7-B8CD-DA2FB8348C2B

Q37394399-BAA45B34-D6D5-4DF2-9C29-7A04DD05A2A1

Q37394399-E82FEF6B-A704-43AE-9DA0-E31E8C7A6117

P577

Q37394399-7FA25BBB-21C6-40BE-B932-2D88D3683DEC

P5875

Q37394399-3EA19F3C-E6CD-45CB-BC7D-58279433E27C

P698

Q37394399-E4A63F23-6ABC-4BE3-8288-122D5E8D3107

P921

Q37394399-3B84EA3C-99D0-49D7-A29D-5AE44159CBA6

Q37394399-B7F27DF2-E1B9-4FC7-9A9A-69D43E7DAD11

P932

Q37394399-78EA40F1-961E-4590-9B45-115B054BDE8A

P356

P1433

P1476

Plasma microRNA 210 levels cor ...... ence in breast cancer patients

@en

P2093

Aman U Buzdar

http://www.w3.org/2001/XMLSchema#string

Eun-Jung Jung

http://www.w3.org/2001/XMLSchema#string

Juyeon Kim

http://www.w3.org/2001/XMLSchema#string

Lajos Pusztai

http://www.w3.org/2001/XMLSchema#string

Soon-Tae Park

http://www.w3.org/2001/XMLSchema#string

Xiao-Feng Le

http://www.w3.org/2001/XMLSchema#string

P2860

A microRNA expression signature of human solid tumors defines cancer gene targets

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1)

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

MicroRNA gene expression deregulation in human breast cancer

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

Reprogramming of miRNA networks in cancer and leukemia.

P304

2603-2614

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.26565

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Libero Santarpia

Francisco J Esteva

George A. Calin

P577

2011-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221866901

http://www.w3.org/2001/XMLSchema#string

P698

22370716

http://www.w3.org/2001/XMLSchema#string

P921

P932

3864019

http://www.w3.org/2001/XMLSchema#string